|
PT97888B
(pt)
|
1990-06-07 |
1998-12-31 |
Zeneca Ltd |
Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
|
|
GB9407447D0
(en)
|
1994-04-14 |
1994-06-08 |
Glaxo Group Ltd |
Chemical compounds
|
|
CA2262502C
(en)
|
1996-07-31 |
2002-11-26 |
Nikken Chemicals Co., Ltd. |
6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
|
|
AU2001270149A1
(en)
|
2000-06-26 |
2002-01-08 |
Merck & Co., Inc. |
Iminopyrimidine nmda nr2b receptor antagonists
|
|
US6610723B2
(en)
|
2001-01-29 |
2003-08-26 |
Hoffmann-La Roche Inc. |
Imidazole derivatives
|
|
EP1490364B1
(en)
|
2002-03-28 |
2007-09-26 |
Eisai R&D Management Co., Ltd. |
7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
|
|
US7005432B2
(en)
|
2002-05-16 |
2006-02-28 |
Hoffman-La Roche Inc. |
Substituted imidazol-pyridazine derivatives
|
|
CA2482838A1
(en)
|
2002-05-31 |
2003-12-11 |
Eisai Co., Ltd. |
Pyrazole compounds and pharmaceutical compositions containing the compound
|
|
WO2005028480A2
(en)
|
2003-09-03 |
2005-03-31 |
Neurogen Corporation |
5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
|
|
EP1720860A1
(en)
|
2004-02-18 |
2006-11-15 |
AstraZeneca AB |
Triazole compounds and their use as metabotropic glutamate receptor antagonists
|
|
US7820654B2
(en)
|
2004-09-23 |
2010-10-26 |
Dr. Reddy's Laboratories Ltd. |
Pyrimidine compounds, process for their preparation and compositions containing them
|
|
EP1814883A1
(en)
|
2004-11-22 |
2007-08-08 |
Vertex Pharmaceuticals Incorporated |
Bicyclic inhibitors or rho kinase
|
|
US7807704B2
(en)
|
2006-03-30 |
2010-10-05 |
Chemocentryx, Inc. |
Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
TWI443090B
(zh)
|
2007-05-25 |
2014-07-01 |
Abbvie Deutschland |
作為代謝性麩胺酸受體２（ｍｇｌｕ２ 受體）之正向調節劑之雜環化合物
|
|
WO2009004430A1
(en)
|
2007-06-29 |
2009-01-08 |
Pfizer Inc. |
N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
|
|
CN101842357A
(zh)
|
2007-08-30 |
2010-09-22 |
武田药品工业株式会社 |
取代的吡唑衍生物
|
|
EP2215073A4
(en)
|
2007-10-31 |
2011-04-06 |
Merck Sharp & Dohme |
SLEEP MODULATION WITH NR2B RECEPTOR ANTAGONISTS
|
|
WO2009118187A1
(en)
|
2008-03-27 |
2009-10-01 |
Evotec Neurosciences Gmbh |
Methods for treating disorders using nmda nr2b-subtype selective antagonist
|
|
JPWO2009157196A1
(ja)
|
2008-06-25 |
2011-12-08 |
武田薬品工業株式会社 |
アミド化合物
|
|
NZ590688A
(en)
|
2008-08-05 |
2012-09-28 |
Daiichi Sankyo Co Ltd |
imidazo[4,5-b]pyridin-2-one derivatives
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
RU2517181C2
(ru)
|
2008-10-16 |
2014-05-27 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
Производные индола и бензоморфолина в качестве модулятора метаботропных глутаматных рецепторов
|
|
KR101048448B1
(ko)
|
2008-11-21 |
2011-07-11 |
한국화학연구원 |
신규 피라졸로[4,3-ｂ]피리딘 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
CA2744498C
(en)
|
2008-11-25 |
2017-10-24 |
University Of Rochester |
Mlk inhibitors and methods of use
|
|
US8969342B2
(en)
|
2009-03-20 |
2015-03-03 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal microbial infections
|
|
US8906914B2
(en)
|
2009-08-18 |
2014-12-09 |
Janssen Pharmaceutica Nv |
Ethylene diamine modulators of fatty acid hydrolase
|
|
EP2579717A4
(en)
|
2010-06-09 |
2013-12-11 |
Merck Sharp & Dohme |
POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
|
|
WO2012102405A1
(ja)
|
2011-01-28 |
2012-08-02 |
佐藤製薬株式会社 |
縮環化合物
|
|
JP2012188363A
(ja)
|
2011-03-09 |
2012-10-04 |
Dainippon Sumitomo Pharma Co Ltd |
アザベンゾイミダゾロン誘導体
|
|
CA2841981A1
(en)
|
2011-07-28 |
2013-01-31 |
Chdi Foundation, Inc. |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
EP2570415B1
(en)
|
2011-09-19 |
2015-08-26 |
Sanofi |
N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
|
|
WO2013060029A1
(en)
*
|
2011-10-28 |
2013-05-02 |
Merck Sharp & Dohme Corp |
Allosteric modulators of metabotropic glutamate receptors
|
|
WO2013130855A1
(en)
|
2012-03-02 |
2013-09-06 |
Takeda Pharmaceutical Company Limited |
Indazole derivatives
|
|
MA37975B2
(fr)
|
2012-09-11 |
2021-03-31 |
Genzyme Corp |
Inhibiteurs de synthase de glucosylcéramide
|
|
SG11201505862TA
(en)
|
2013-01-29 |
2015-08-28 |
Naurex Inc |
Spiro-lactam nmda receptor modulators and uses thereof
|
|
WO2014124651A1
(en)
|
2013-02-15 |
2014-08-21 |
Københavns Universitet |
Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
|
|
TW201444820A
(zh)
|
2013-03-13 |
2014-12-01 |
Abbvie Inc |
吡啶ｃｄｋ９激酶抑制劑
|
|
SG11201506687RA
(en)
|
2013-03-15 |
2015-09-29 |
Plexxikon Inc |
Heterocyclic compounds and uses thereof
|
|
CA2915838C
(en)
|
2013-06-21 |
2023-04-18 |
Zenith Epigenetics Corp. |
Bicyclic bromodomain inhibitors
|
|
CA2918242C
(en)
|
2013-07-31 |
2022-06-21 |
Merck Patent Gmbh |
Pyridines, pyrimidines, and pyrazines, as btk inhibitors and uses thereof
|
|
ES2791252T3
(es)
|
2014-08-15 |
2020-11-03 |
Janssen Pharmaceuticals Inc |
Pirazoles
|
|
WO2016025917A1
(en)
|
2014-08-15 |
2016-02-18 |
Janssen Pharmaceuticals, Inc. |
Triazoles as nr2b receptor inhibitors
|
|
US12006328B2
(en)
|
2014-11-18 |
2024-06-11 |
Emory University |
Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto
|
|
MA41803A
(fr)
|
2015-03-24 |
2018-01-30 |
Almirall Sa |
Dérivés amino-indazoles utilisés comme inhibiteurs des canaux sodiques
|
|
HRP20200410T1
(hr)
*
|
2015-07-09 |
2020-08-21 |
Janssen Pharmaceutica Nv |
Supstituirani 4-azaindoli i njihova upotreba kao modulatora glun2b receptora
|
|
BR112018016329A2
(pt)
|
2016-02-10 |
2018-12-18 |
Janssen Pharmaceutica Nv |
1,2,3-triazóis substituídos como moduladores de nmda seletivos para nr2b
|
|
TW201819376A
(zh)
|
2016-10-06 |
2018-06-01 |
比利時商健生藥品公司 |
經取代之１Ｈ－咪唑並［４，５－ｂ］吡啶－２（３Ｈ）－酮及其作為ＧＬＵＮ２Ｂ受體調節劑之用途
|
|
IL271149B2
(en)
|
2017-06-14 |
2024-05-01 |
Trevena Inc |
Compounds for modulating s1p1 activity and methods of using the same
|
|
US10766893B2
(en)
|
2017-12-20 |
2020-09-08 |
H. Lundbeck A/S |
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
|
|
WO2019193516A2
(en)
|
2018-04-04 |
2019-10-10 |
Janssen Pharmaceutica Nv |
Substituted pyridine and pyrimidines and their use as glun2b receptor modulators
|
|
CN110294756A
(zh)
|
2019-06-04 |
2019-10-01 |
广州市原子高科同位素医药有限公司 |
GluN2B亚基靶向型中枢神经系统正电子示踪剂及其制备
|
|
SG11202112405VA
(en)
|
2019-06-14 |
2021-12-30 |
Janssen Pharmaceutica Nv |
Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulators
|
|
CN113950357A
(zh)
|
2019-06-14 |
2022-01-18 |
詹森药业有限公司 |
吡嗪氨基甲酸酯及其作为GluN2B受体调节剂的用途
|
|
MX2021015508A
(es)
|
2019-06-14 |
2022-01-31 |
Janssen Pharmaceutica Nv |
Carbamatos de piridina y su uso como moduladores del receptor glun2b.
|
|
CN113939306B
(zh)
|
2019-06-14 |
2024-07-19 |
德彪药业国际股份公司 |
用于治疗涉及生物膜的细菌感染的药物及其用途
|
|
KR20220024403A
(ko)
|
2019-06-14 |
2022-03-03 |
얀센 파마슈티카 엔.브이. |
치환된 피라졸로-피라진 및 이들의 glun2b 수용체 조절제로서의 용도
|
|
AU2020293642A1
(en)
|
2019-06-14 |
2022-01-20 |
Janssen Pharmaceutica Nv |
Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators
|
|
CN113993868A
(zh)
|
2019-06-14 |
2022-01-28 |
詹森药业有限公司 |
取代的吡唑并吡啶酰胺以及它们作为glun2b受体调节剂的用途
|
|
UY38806A
(es)
|
2019-08-01 |
2021-02-26 |
Novartis Ag |
Compuestos inhibidores tricíclicos de kars dependientes de akr1c3, composiciones y sus usos
|
|
EP4027993A4
(en)
*
|
2019-09-13 |
2023-09-20 |
The Broad Institute Inc. |
Cyclooxygenase-2 inhibitors and uses thereof
|
|
WO2021250521A1
(en)
|
2020-06-09 |
2021-12-16 |
Array Biopharma Inc. |
4-oxo-3,4-dihydroquinazolinon compounds for the treatment of braf-associated diseases and disorders
|